PipelineReview.com2m
GIOSTAR Announces FDA Clearance of the IND for Starting PHASE-2 Clinical Trial for Developing Specific Stem Cell Therapy for Type II Diabetes.
Diabetes is not just a disease but a global health crisis ... of the client from the pharmaceutical or biotechnology industry. SAN DIEGO, CA, USA I November 13, 2024 I Global Institute of Stem Cell ...
Daily55m
Annual DXA Screening in Lung Transplant Patients in First Two Years may help prevent osteoporosis: Study
USA: A recent study recommends that lung transplant patients undergo annual screening with dual-energy X-ray absorptiometry ...
medtechdive41m
Dean Kamen, insulin pump pioneer, wants to shake up diabetes tech
Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...
How the COVID-19 pandemic impacted Americans’ drinking habits
In today’s health headlines, how did the COVID-19 pandemic impact Americans’ drinking habits? Plus, researchers claim a new ...
Le Lézard15m
ASJ Open Forum Announces Breakthrough Inaugural Impact Factor of 1.6
ASJ Open Forum (ASJOF), the open-access companion journal to Aesthetic Surgery Journal (ASJ), is thrilled to announce the achievement of a 1.6 impact factor, ranking it in the top 50% of surgical ...